skip to content

SEC Charges Kiromic BioPharma and Two Former C-Suite Executives with Misleading Investors about Status of FDA Reviews

Dec 3, 2024

The Securities and Exchange Commission today filed settled charges against Houston-based biotherapeutics company Kiromic BioPharma, Inc., its former CEO, Maurizio Chiriva-Internati, and its former chief financial officer, Tony Tontat, for failing to…

Full report at: Read More

More News

SEC Seeks Candidates for Membership on the Investor Advisory Committee

FROM: Securities Law

SEC Charges One Oak Capital Management and Michael DeRosa with Breaching Fiduciary Duties to Clients

FROM: Securities Law

Wirtz Law Hits $60 Million Milestone in California Lemon Law Wins

FROM: Personal Injury Law

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

SEC Charges Kiromic BioPharma and Two Former C-Suite Executives with Misleading Investors about Status of FDA Reviews

More News

Deutsche Bank Subsidiary DWS to Pay $25 Million for Anti-Money Laundering Violations and Misstatements Regarding ESG Investments

Robert Del Prete

Readout of Secretary Raimondo’s Meeting with Indonesia’s Coordinating Minister for Maritime and Investment Affairs Luhut Pandjaitan

SEC Approves Funding Amendment to National Market System Plan Governing the Consolidated Audit Trail

California Consumer Attorneys, P.C. Celebrates Landmark Victory in Lemon Law Trial

SEC Charges 16 Wall Street Firms with Widespread Recordkeeping Failures

SEC Seeks Candidates for Membership on the Investor Advisory Committee

SEC Charges One Oak Capital Management and Michael DeRosa with Breaching Fiduciary Duties to Clients

Wirtz Law Hits $60 Million Milestone in California Lemon Law Wins

Get Weekly Legal News Summaries from Law.cards!